NYSE:PACS - New York Stock Exchange, Inc. - US69380Q1076 - Common Stock - Currency: USD
PACS GROUP INC
NYSE:PACS (2/4/2025, 8:04:01 PM)
Premarket: 14.33 0 (0%)14.33
0 (0%)
The current stock price of PACS is 14.33 USD. In the past month the price increased by 7.34%.
/PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against PACS Group, Inc. ("PACS" or the "Company") (NYSE: PACS). Such...
/PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of PACS Group, Inc. (NYSE: PACS). Shareholders who purchased shares of PACS...
/PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against PACS Group, Inc. ("PACS" or "the Company") (NYSE: PACS) for violations of...
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
HCA | HCA HEALTHCARE INC | 15.14 | 84.80B | ||
BKDT | BROOKDALE SENIOR LIVING - BKD 7 11/15/25 | N/A | 13.68B | ||
THC | TENET HEALTHCARE CORP | 12.9 | 13.67B | ||
UHS | UNIVERSAL HEALTH SERVICES-B | 12.97 | 12.71B | ||
EHC | ENCOMPASS HEALTH CORP | 24.03 | 10.19B | ||
ENSG | ENSIGN GROUP INC/THE | 27.48 | 8.33B | ||
ACHC | ACADIA HEALTHCARE CO INC | 12.84 | 4.19B | ||
SGRY | SURGERY PARTNERS INC | 27.34 | 3.27B | ||
CON | CONCENTRA GROUP HOLDINGS PAR | 8.8 | 2.99B | ||
SEM | SELECT MEDICAL HOLDINGS CORP | 9.43 | 2.60B | ||
ARDT | ARDENT HEALTH PARTNERS INC | 40.03 | 2.17B | ||
NHC | NATIONAL HEALTHCARE CORP | 12.74 | 1.57B |
Pacs Group Inc is a US-based company operating in Health Care Providers & Services industry. The company is headquartered in Farmington, Utah and currently employs 32,433 full-time employees. The company went IPO on 2024-04-11. PACS Group, Inc. is a holding company investing in post-acute healthcare facilities, professionals, and ancillary services. The firm is focused on delivering skilled nursing care through a portfolio of independently operated facilities. The company also provides its independently operated facilities with a comprehensive suite of technology, support, and back-office services. The post-acute care ecosystem serves individuals who need additional help recuperating from acute conditions, illnesses, or serious medical procedures after they have been discharged from the hospital. This ecosystem ranges from higher acuity, higher-cost settings, such as long-term acute care hospitals and inpatient rehabilitation facilities, to lower acuity, lower-cost settings, such as assisted living facilities, and home health. The Company’s independent subsidiaries operate about 284 post-acute care and senior living facilities across 16 states, serving over 27,000 patients daily.
PACS GROUP INC
262 N University Ave.
Farmington UTAH US
Employees: 32433
Company Website: https://pacs.com/
Phone: 18014479829
The current stock price of PACS is 14.33 USD.
The exchange symbol of PACS GROUP INC is PACS and it is listed on the New York Stock Exchange, Inc. exchange.
PACS stock is listed on the New York Stock Exchange, Inc. exchange.
Always make your own analysis. On these pages you can find a full technical and fundamental analysis report for PACS, which may be a starting point for your analysis. You can also find the financials, news, analyst ratings and estimates here, which can be used to increase your understanding of PACS.
PACS does not pay a dividend.
The PE ratio for PACS is 18.86. This is based on the reported non-GAAP earnings per share of 0.76 and the current share price of 14.33 USD.
The outstanding short interest for PACS is 9.15% of its float.
ChartMill assigns a technical rating of 1 / 10 to PACS.
ChartMill assigns a fundamental rating of 3 / 10 to PACS. PACS has a bad profitability rating. Also its financial health evaluation is rather negative.
Over the last trailing twelve months PACS reported a non-GAAP Earnings per Share(EPS) of 0.76. The EPS increased by -25% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | 3.63% | ||
ROA | 2.9% | ||
ROE | 19.73% | ||
Debt/Equity | 0.9 |
ChartMill assigns a Buy % Consensus number of 83% to PACS. The Buy consensus is the average rating of analysts ratings from 13 analysts.
For the next year, analysts expect an EPS growth of 40.21% and a revenue growth 30.36% for PACS